• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习平台发现淋病奈瑟菌的新型生长抑制剂。

Machine Learning Platform to Discover Novel Growth Inhibitors of Neisseria gonorrhoeae.

机构信息

Department of Pharmacology, Physiology, and Neuroscience, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA.

Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC, 27606, USA.

出版信息

Pharm Res. 2020 Jul 13;37(7):141. doi: 10.1007/s11095-020-02876-y.

DOI:10.1007/s11095-020-02876-y
PMID:32661900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8274436/
Abstract

PURPOSE

To advance fundamental biological and translational research with the bacterium Neisseria gonorrhoeae through the prediction of novel small molecule growth inhibitors via naïve Bayesian modeling methodology.

METHODS

Inspection and curation of data from the publicly available ChEMBL web site for small molecule growth inhibition data of the bacterium Neisseria gonorrhoeae resulted in a training set for the construction of machine learning models. A naïve Bayesian model for bacterial growth inhibition was utilized in a workflow to predict novel antibacterial agents against this bacterium of global health relevance from a commercial library of >10 drug-like small molecules. Follow-up efforts involved empirical assessment of the predictions and validation of the hits.

RESULTS

Specifically, two small molecules were found that exhibited promising activity profiles and represent novel chemotypes for agents against N. gonorrrhoeae.

CONCLUSIONS

This represents, to the best of our knowledge, the first machine learning approach to successfully predict novel growth inhibitors of this bacterium. To assist the chemical tool and drug discovery fields, we have made our curated training set available as part of the Supplementary Material and the Bayesian model is accessible via the web. Graphical Abstract.

摘要

目的

通过基于朴素贝叶斯建模方法预测新型小分子生长抑制剂,推进淋病奈瑟菌的基础生物学和转化研究。

方法

从公开的 ChEMBL 网站上检查和整理淋病奈瑟菌小分子生长抑制数据,为构建机器学习模型提供了一个训练集。利用朴素贝叶斯模型对细菌生长抑制进行建模,作为工作流程的一部分,从一个超过 10 种药物样小分子的商业文库中预测针对这种具有全球健康相关性的细菌的新型抗菌剂。后续的工作包括对预测结果进行实证评估和验证命中结果。

结果

具体来说,发现了两种具有有前景的活性特征的小分子,它们代表了针对淋病奈瑟菌的新型化学型药物。

结论

据我们所知,这是第一个成功预测这种细菌新型生长抑制剂的机器学习方法。为了协助化学工具和药物发现领域,我们将经过整理的训练集作为补充材料的一部分提供,并且可以通过网络访问贝叶斯模型。图表摘要。

相似文献

1
Machine Learning Platform to Discover Novel Growth Inhibitors of Neisseria gonorrhoeae.机器学习平台发现淋病奈瑟菌的新型生长抑制剂。
Pharm Res. 2020 Jul 13;37(7):141. doi: 10.1007/s11095-020-02876-y.
2
Efficacy of a Novel Tricyclic Topoisomerase Inhibitor in a Murine Model of Neisseria gonorrhoeae Infection.一种新型三环拓扑异构酶抑制剂在淋病奈瑟菌感染小鼠模型中的疗效
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5592-4. doi: 10.1128/AAC.00913-16. Print 2016 Sep.
3
Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae.格帕沙星(GSK2140944)对淋病奈瑟菌的活性。
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02047-16. Print 2017 Mar.
4
Neisseria gonorrhoeae and fosfomycin: Past, present and future.淋病奈瑟菌与磷霉素:过去、现在与未来。
Int J Antimicrob Agents. 2015 Sep;46(3):290-6. doi: 10.1016/j.ijantimicag.2015.05.007. Epub 2015 Jun 19.
5
Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226.针对淋病奈瑟菌ATCC 49226的格派沙星(GSK2140944)琼脂稀释法质量控制测定的多中心研究。
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4404-6. doi: 10.1128/AAC.00527-16. Print 2016 Jul.
6
Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein.淋病奈瑟菌的多药耐药性:MtrD 外排蛋白中功能重要残基的鉴定。
mBio. 2019 Nov 19;10(6):e02277-19. doi: 10.1128/mBio.02277-19.
7
Prospects of untreatable gonorrhea and ways forward.无法治愈的淋病前景及未来方向。
Future Microbiol. 2015;10(3):313-6. doi: 10.2217/fmb.14.138.
8
The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.乌干达拉科尔圣玛丽医院门诊患者中淋病奈瑟菌的流行情况及抗生素敏感性模式。
J Prev Med Hyg. 2012 Dec;53(4):186-9.
9
Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013.抗微生物药物处方与淋病奈瑟菌耐药性,美国,2005-2013 年。
Emerg Infect Dis. 2017 Oct;23(10):1657-1663. doi: 10.3201/eid2310.170488.
10
Antimicrobial sensitivity of Neisseria gonorrhoeae: a hospital-based study from Kuwait.淋病奈瑟菌的抗菌敏感性:一项来自科威特的基于医院的研究。
J Chemother. 2005 Feb;17(1):117-8. doi: 10.1179/joc.2005.17.1.117.

引用本文的文献

1
A comprehensive review for machine learning based human papillomavirus detection in forensic identification with multiple medical samples.基于机器学习的多医学样本法医鉴定中人类乳头瘤病毒检测的综合综述。
Front Microbiol. 2023 Jul 17;14:1232295. doi: 10.3389/fmicb.2023.1232295. eCollection 2023.
2
Random Forest Model Predictions Afford Dual-Stage Antimalarial Agents.随机森林模型预测双重抗疟药物。
ACS Infect Dis. 2022 Aug 12;8(8):1553-1562. doi: 10.1021/acsinfecdis.2c00189. Epub 2022 Jul 27.
3
Aglow: A Fluorescence Assay and Machine Learning Model to Identify Inhibitors of Intracellular Infection.

本文引用的文献

1
A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA.一种靶向结核分枝杆菌KasA的临床前候选药物。
Cell Chem Biol. 2020 May 21;27(5):560-570.e10. doi: 10.1016/j.chembiol.2020.02.007. Epub 2020 Mar 19.
2
Antitubercular Triazines: Optimization and Intrabacterial Metabolism.抗结核三嗪类化合物:优化与菌内代谢。
Cell Chem Biol. 2020 Feb 20;27(2):172-185.e11. doi: 10.1016/j.chembiol.2019.10.010. Epub 2019 Nov 8.
3
Intrabacterial Metabolism Obscures the Successful Prediction of an InhA Inhibitor of .细菌内代谢掩盖了对一种InhA抑制剂的成功预测。
发光法:一种用于鉴定细胞内感染抑制剂的荧光检测法和机器学习模型。
ACS Infect Dis. 2022 Jul 8;8(7):1280-1290. doi: 10.1021/acsinfecdis.2c00014. Epub 2022 Jun 24.
4
Mycobacterium abscessus drug discovery using machine learning.利用机器学习发现脓肿分枝杆菌药物。
Tuberculosis (Edinb). 2022 Jan;132:102168. doi: 10.1016/j.tube.2022.102168. Epub 2022 Jan 20.
5
Bayesian Modeling and Intrabacterial Drug Metabolism Applied to Drug-Resistant .贝叶斯建模和菌内药物代谢在耐药性中的应用。
ACS Infect Dis. 2021 Aug 13;7(8):2508-2521. doi: 10.1021/acsinfecdis.1c00265. Epub 2021 Aug 3.
6
Discovery of 5-Nitro-6-thiocyanatopyrimidines as Inhibitors of and .发现5-硝基-6-硫氰基嘧啶作为[具体酶名称1]和[具体酶名称2]的抑制剂。 (你提供的原文中“and.”部分不完整,这里补充了“[具体酶名称1]和[具体酶名称2]”以便完整理解句子意思,实际翻译时请根据准确内容进行调整)
ACS Med Chem Lett. 2021 Apr 7;12(5):774-781. doi: 10.1021/acsmedchemlett.1c00038. eCollection 2021 May 13.
7
Random Forest Model Prediction of Compound Oral Exposure in the Mouse.小鼠复合口服暴露的随机森林模型预测
ACS Pharmacol Transl Sci. 2021 Jan 26;4(1):338-343. doi: 10.1021/acsptsci.0c00197. eCollection 2021 Feb 12.
ACS Infect Dis. 2019 Dec 13;5(12):2148-2163. doi: 10.1021/acsinfecdis.9b00295. Epub 2019 Nov 5.
4
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA.结核分枝杆菌 KasA 的双抑制剂的协同致死性。
mBio. 2018 Dec 18;9(6):e02101-17. doi: 10.1128/mBio.02101-17.
5
Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.1996-2016 年日本福冈淋病奈瑟菌分离株的抗菌药物耐药性及分子特征
J Glob Antimicrob Resist. 2019 Jun;17:3-7. doi: 10.1016/j.jgar.2018.11.011. Epub 2018 Nov 15.
6
Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.淋病奈瑟菌的耐药性:STAR 性传播感染临床研究组计划会议记录。
Sex Transm Dis. 2019 Mar;46(3):e18-e25. doi: 10.1097/OLQ.0000000000000929.
7
Naïve Bayesian Models for Vero Cell Cytotoxicity.用于 Vero 细胞细胞毒性的朴素贝叶斯模型。
Pharm Res. 2018 Jun 29;35(9):170. doi: 10.1007/s11095-018-2439-9.
8
Treatment of human challenge and MDR strains of Neisseria gonorrhoeae with LpxC inhibitors.用 LpxC 抑制剂治疗淋病奈瑟菌的人体挑战和耐多药株。
J Antimicrob Chemother. 2018 Aug 1;73(8):2064-2071. doi: 10.1093/jac/dky151.
9
Identification of Novel Neisseria gonorrhoeae Lineages Harboring Resistance Plasmids in Coastal Kenya.鉴定肯尼亚沿海地区携带耐药质粒的新型淋病奈瑟菌谱系。
J Infect Dis. 2018 Jul 24;218(5):801-808. doi: 10.1093/infdis/jiy240.
10
Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery.比较和验证用于结核分枝杆菌药物发现的机器学习模型。
Mol Pharm. 2018 Oct 1;15(10):4346-4360. doi: 10.1021/acs.molpharmaceut.8b00083. Epub 2018 Apr 26.